Product Description
Thymosin Beta-4 is a ubiquitous 43-amino-acid protein that binds monomeric G-actin and regulates cytoskeletal dynamics. Research models show it drives cell migration toward injury sites, upregulates VEGF-mediated angiogenesis, and modulates inflammatory cytokine profiles. Unlike BPC-157, which works best injected near the injury, TB4 operates systemically — remote injection delivers comparable effects across multiple tissue compartments.









